Correlia Biosystems
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $9.6M
Investors
- 4
About Correlia Biosystems
Correlia Biosystems, Inc.Founded in 2013 in Berkeley, US, Correlia Biosystems, Inc. specializes in biotechnology solutions, focusing on diagnostics and therapeutics. The company was established by Akwasi Apori and Kursad Araz.861 mn.Correlia specializes in developing biotechnology solutions to meet critical needs in the life sciences sector. Their core offerings consist of advanced diagnostic tools and therapeutic platforms that utilize proprietary technologies for genetic analysis and disease management.Correlia generates revenue through direct sales of its diagnostic and therapeutic products to healthcare providers and research institutions. The company operates a business-to-business model, partnering with hospitals and laboratories for product distribution. The company is focusing on launching new diagnostic tools and therapeutic platforms within the next year while targeting expansion into European and Asian markets by 2025.
Who invested in Correlia Biosystems
4 investors across 2 rounds
See all investors in Correlia Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Correlia Biosystems
Who invested in Correlia Biosystems?
Correlia Biosystems has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Correlia Biosystems raised?
Correlia Biosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Correlia Biosystems last raise money?
Correlia Biosystems's most recent round on record is a Series A, in Oct 2020.
What does Correlia Biosystems do?
Correlia Biosystems is a biotechnology company.
Where is Correlia Biosystems headquartered?
Correlia Biosystems is headquartered in Berkeley, US.
Which VCs invest in companies like Correlia Biosystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Correlia Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Correlia Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.